Laura D'Erasmo Selected Research

Costello Syndrome

1/2021	Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS).
10/2020	Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia.
7/2018	Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
1/2018	Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura D'Erasmo Research Topics

Disease

9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
8	Atherosclerosis 11/2022 - 01/2017
6	Homozygous Familial Hypercholesterolemia 01/2022 - 01/2017
4	Dyslipidemias (Dyslipidemia) 11/2022 - 01/2017
4	Non-alcoholic Fatty Liver Disease 03/2022 - 12/2019
4	Costello Syndrome 01/2021 - 01/2018
4	Insulin Resistance 01/2021 - 01/2017
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 01/2017
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2021 - 01/2018
3	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2021 - 07/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2019
3	Pancreatitis 01/2020 - 01/2018
2	Hypercholesterolemia 01/2021 - 01/2017
2	Hypertriglyceridemia 10/2020 - 12/2019
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2020 - 01/2018
1	Hemorrhagic Stroke 02/2021
1	Stroke (Strokes) 02/2021
1	Coronary Disease (Coronary Heart Disease) 02/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2021
1	Overweight 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Infections 01/2021
1	Obesity 01/2021
1	Genetic Risk Score 01/2021
1	Prediabetic State (Prediabetes) 01/2021
1	COVID-19 01/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2021
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Inflammation (Inflammations) 01/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Cryptogenic Cirrhosis 12/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2019
1	Fatty Liver 09/2017
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 09/2017
1	2 Familial Hypobetalipoproteinemia 09/2017

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 01/2022 - 01/2017
9	CholesterolIBA 11/2022 - 01/2017
8	oxidized low density lipoproteinIBA 01/2022 - 01/2017
8	Triglycerides (Triacylglycerol)IBA 01/2021 - 09/2017
7	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2017
6	LDL CholesterolIBA 01/2022 - 09/2017
5	BMS201038IBA 01/2022 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2021
2	Transaminases (Aminotransferases)IBA 01/2022 - 01/2017
2	ISIS 304801IBA 01/2021 - 10/2020
2	CalciumIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
2	Antisense OligonucleotidesIBA 10/2020 - 01/2020
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2020 - 07/2018
1	AcyltransferasesIBA 03/2022
1	glucokinase regulatory proteinIBA 03/2022
1	Phospholipases (Phospholipase)IBA 03/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Proprotein Convertase 9IBA 07/2021
1	Peptides (Polypeptides)IBA 07/2021
1	Ezetimibe (Zetia)FDA Link 07/2021
1	EnzymesIBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Lipoprotein(a)IBA 01/2021
1	HDL LipoproteinsIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	ApoproteinsIBA 12/2020
1	Apolipoprotein C-IIIIBA 10/2020
1	Biological ProductsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2019
1	Angiopoietin-Like Protein 3IBA 01/2019
1	AlbuminsIBA 01/2019
1	Apolipoprotein C-II (ApoC2)IBA 07/2018
1	Proteins (Proteins, Gene)FDA Link 07/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	HDL CholesterolIBA 09/2017
1	Apolipoproteins B (ApoB)IBA 09/2017
1	ApolipoproteinsIBA 09/2017

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2017
3	Blood Component Removal (Apheresis) 01/2022 - 01/2017
1	Secondary Prevention 02/2021